ChoA Pharmaceutical Co., LTD.

A034940

KR7034940007

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
1,613 ^KRW	-0.12%		-0.62%	-18.58%

2023	ChoA Pharmaceutical Co., LTD. Reports Earnings Results for the Full Year Ended December 31, 2022	CI
2022	ChoA Pharmaceutical Co., LTD.(KOSDAQ:A034940) dropped from S&P Global BMI Index	CI

ChoA Pharmaceutical Co.,Ltd(KOSDAQ:A034940) added to S&P Global BMI Index

September 21, 2020 at 12:00 am EDT

Latest news about ChoA Pharmaceutical Co., LTD.

ChoA Pharmaceutical Co., LTD. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-17	CI
ChoA Pharmaceutical Co., LTD.(KOSDAQ:A034940) dropped from S&P Global BMI Index	22-09-19	CI
ChoA Pharmaceutical Co.,Ltd(KOSDAQ:A034940) added to S&P Global BMI Index	20-09-21	CI
ChoA Pharmaceutical Co., Ltd.(KOSDAQ:A034940) dropped from S&P Global BMI Index	19-09-23	CI
ChoA Pharmaceutical Co., Ltd. announced that it has received KRW 12 billion in funding from Moorim Capital Co., Ltd., Dongbu Securities Co., Ltd., Investment Arm, Shinhan Investment Corp., Investment Arm	17-10-23	CI
ChoA Pharmaceutical Co., Ltd. announced that it expects to receive KRW 12 billion in funding from Moorim Capital Co., Ltd., Dongbu Securities Co., Ltd., Investment Arm, Shinhan Investment Corp., Investment Arm and other investors	17-10-19	CI

Chart ChoA Pharmaceutical Co., LTD.

Duration

Period

More charts

CHOA PHARMACEUTICAL CO,.LTD is a Korea-based company engaged in the manufacture of pharmaceuticals. The Companyâs products are mainly for treatment of indigestion, gastric ulcer, duodenal ulcer, gastritis, gastric hyperacidity, intestinal disorder, constipation, diarrhea, stomachache, calcium deficiency, fatigue, iron deficiency anemia, neurasthenia, hypertension, hyperlipidemia, circulatory disorder, medicine poisoning, hepatic disease, allergic rhinitis, cough, cold, rheumatoid arthritis and others. It also provides nutrition products, health drinks, mixed drinks, beverages for children, cosmetics and others.

Sector

Pharmaceuticals

Calendar

2024-05-12 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
CHOA PHARMACEUTICAL CO., LTD.	-18.58%	36.11M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19.27%	43.18B
OTSUKA HOLDINGS CO., LTD.	+24.05%	23.23B
SANDOZ GROUP AG	+15.11%	14.6B
CIPLA LIMITED	+12.33%	13.54B
ZYDUS LIFESCIENCES LIMITED	+38.36%	11.5B
ONO PHARMACEUTICAL CO., LTD.	-7.63%	6.79B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+10.21%	5.31B